Similar medications and substitutes for DOSTARLIMAB
In short: Jemperli (DOSTARLIMAB) belongs to the Programmed Death Receptor-1 Blocking Antibody class. The medications listed below either share that mechanism of action or have been clinically validated as substitutes when Jemperli is unsuitable due to side effects, cost, availability, or contraindications.
No alternatives are listed for Jemperli in our database yet. Browse the full medicine index or consult your pharmacist for substitution advice.